Julia Mayerle Selected Research

Julia Mayerle Research Topics

Disease

56	Pancreatitis 05/2024 - 02/2002
39	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 04/2003
29	Neoplasms (Cancer) 04/2024 - 04/2003
28	Chronic Pancreatitis 12/2023 - 11/2003
22	Adenocarcinoma 01/2024 - 04/2003
13	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2019
9	Fibrosis (Cirrhosis) 01/2022 - 06/2007
9	Inflammation (Inflammations) 11/2021 - 10/2010
8	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 07/2014
8	Infections 01/2022 - 10/2005
7	Pain (Aches) 06/2022 - 10/2005
6	Necrosis 01/2021 - 12/2004
6	Hereditary pancreatitis 07/2020 - 02/2002
5	Autoimmune Pancreatitis 01/2024 - 06/2007
5	COVID-19 12/2023 - 07/2021
5	Acute Necrotizing Pancreatitis 01/2023 - 12/2003
5	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2011
4	Disease Progression 07/2023 - 09/2016
4	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 06/2006
3	Gallstones (Gallstone) 05/2024 - 06/2013
3	Liver Neoplasms (Liver Cancer) 01/2023 - 10/2019
3	Abdominal Pain (Pain, Abdominal) 01/2022 - 11/2008
3	Liver Diseases (Liver Disease) 01/2021 - 07/2014
3	Diabetes Mellitus 01/2020 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 08/2011
3	Pancreatic Pseudocyst 01/2017 - 03/2008
3	Body Weight (Weight, Body) 01/2016 - 07/2012
2	Carcinogenesis 04/2024 - 02/2012
2	Ulcerative Colitis 01/2022 - 08/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 05/2014
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2019
2	Hepatic Encephalopathy 08/2020 - 01/2020
2	Sepsis (Septicemia) 02/2020 - 01/2019
2	Margins of Excision 01/2019 - 02/2014

Drug/Important Bio-Agent (IBA)

18	CeruletideIBA 01/2021 - 10/2005
17	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 11/2003
14	TrypsinogenIBA 05/2020 - 02/2002
13	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
13	TrypsinIBA 01/2021 - 02/2002
9	Lipase (Acid Lipase)FDA Link 01/2022 - 08/2008
9	Proteins (Proteins, Gene)FDA Link 10/2021 - 04/2003
9	Cathepsin BIBA 11/2019 - 06/2002
8	Gemcitabine FDA Link 01/2024 - 01/2014
8	Kazal Pancreatic Trypsin InhibitorIBA 03/2022 - 06/2006
8	EnzymesIBA 10/2021 - 11/2003
7	Immunoglobulin G (IgG)IBA 01/2024 - 06/2007
6	LigandsIBA 10/2022 - 05/2007
6	Messenger RNA (mRNA)IBA 11/2021 - 04/2003
6	Anti-Bacterial Agents (Antibiotics)IBA 06/2019 - 12/2003
5	CalciumIBA 12/2023 - 02/2002
5	C-Reactive ProteinIBA 01/2022 - 12/2003
5	CytokinesIBA 01/2020 - 06/2006
5	Cadherins (E-Cadherin)IBA 01/2020 - 04/2003
4	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 01/2019
4	IronIBA 01/2022 - 12/2011
4	LipopolysaccharidesIBA 01/2022 - 10/2020
4	AntibodiesIBA 12/2021 - 03/2013
4	Pancreatic Elastase (Elastase)IBA 01/2020 - 03/2014
4	Enzyme Precursors (Zymogens)IBA 11/2019 - 11/2003
4	Phosphotransferases (Kinase)IBA 01/2019 - 02/2012
3	Histones (Histone)IBA 01/2024 - 03/2012
3	LipidsIBA 12/2021 - 12/2015
3	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 01/2011
3	Amylases FDA Link 05/2020 - 08/2008
3	Leukocyte Elastase (Neutrophil Elastase)IBA 11/2019 - 10/2005
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 10/2005
3	Cathepsin LIBA 01/2018 - 02/2010
3	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 02/2016 - 04/2015
3	Ethanol (Ethyl Alcohol)IBA 07/2015 - 11/2003
2	BilirubinIBA 05/2024 - 01/2020
2	NivolumabIBA 07/2023 - 12/2020
2	16S Ribosomal RNAIBA 01/2023 - 01/2019
2	Peptides (Polypeptides)IBA 05/2022 - 03/2015
2	Vitamin D FDA LinkGeneric 01/2022 - 12/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2019
2	Opiate AlkaloidsIBA 01/2022 - 10/2005
2	Bevacizumab (Avastin)FDA Link 01/2022 - 08/2011
2	VaccinesIBA 12/2021 - 10/2021
2	AlbuminsIBA 10/2021 - 01/2021
2	Cell-Free Nucleic AcidsIBA 01/2021 - 10/2019
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2021 - 02/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2020 - 02/2015
2	Cathepsin DIBA 02/2020 - 01/2018
2	InflammasomesIBA 01/2020 - 06/2014
2	Cathepsin GIBA 11/2019 - 11/2019
2	Serine Proteases (Serine Protease)IBA 11/2019 - 11/2019
2	ProcalcitoninIBA 06/2019 - 09/2011

Therapy/Procedure

27	Therapeutics 10/2023 - 01/2011
8	Injections 01/2021 - 08/2008
7	Drug Therapy (Chemotherapy) 01/2024 - 02/2014
6	Length of Stay 12/2017 - 10/2010
5	Enteral Nutrition (Feeding, Tube) 01/2022 - 12/2003
5	Parenteral Nutrition 01/2022 - 12/2003
4	Ligation 12/2020 - 09/2015
4	Adjuvant Chemotherapy 11/2019 - 02/2014
3	Precision Medicine 04/2020 - 02/2016
3	Intraperitoneal Injections 01/2020 - 06/2015
3	Conservative Treatment 04/2019 - 12/2003
2	Immunotherapy 04/2024 - 04/2017
2	Artificial Respiration (Mechanical Ventilation) 07/2021 - 09/2011